Physician profile
Thomas Powell
NPI 1790742054
$3,552.48
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,455 · 2020: $33.64 · 2022: $63.55.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $586.28 | 2019-2020 | |
| Amgen INC. | $580.51 | 2019 | |
| Abbvie INC. | $388.84 | 2019 | |
| Celgene Corporation | $296.65 | 2019 | |
| Horizon Therapeutics Plc | $285.46 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $264.74 | 2019 | |
| Pfizer INC. | $225.32 | 2019 | |
| Ucb, INC. | $161.95 | 2019 | |
| Glaxosmithkline, LLC. | $155.77 | 2019 | |
| Mallinckrodt Enterprises LLC | $146.76 | 2019 | |
| Antares Pharma, INC. | $125.54 | 2019 | |
| Lilly USA, LLC | $89.28 | 2019 | |
| Ani Pharmaceuticals, INC. | $63.55 | 2022 | |
| Genzyme Corporation | $56.49 | 2019 | |
| Pacira Therapeutics, INC. | $41.37 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $40.24 | 2019 | |
| Genentech USA, INC. | $24.38 | 2019 | |
| Radius Health, INC. | $19.35 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Powell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.